Search Results for "Progressive Supranuclear Palsy And Obesity"
Original Source: Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
Background: Progressive supranuclear palsy (PSP) is a neurodegenerative disorder pathologically characterized by neuronal loss, gliosis and tau-positive neurofibrillary tangles in basal ganglia, brainstem and cerebellar nuclei. Five presenting clinical syndromes of PSP are well-described: (i) the classic Richardson's syndrome; (ii) asymmetric parkinsonism with tremor; (iii) freezing of gait; (iv) asymmetric limb apraxia, and (v) apraxia of speech. Aim: To determine whether autopsy-proven PSP cases may prese...
Matching Channels
Progressive Supranuclear Palsy
Primary lateral sclerosis and progressive pseudobulbar palsy
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dic...
Matching News
Allon Therapeutics' davunetide trial for PSP fails
Allon Therapeutics' clinical trial to assess davunetide efficacy in curing progressive supranuclear palsy (PSP) has failed to show efficacy.
Botulinum Toxin Benefits Many PSP Patients With Dystonia
For patients with progressive supranuclear palsy, botulinum toxin A injections relieve disabling blepharospasm and neck and hand dystonia. The greatest benefit is in treating blepharospasm. Medscape...
CNS Drug Development Claims Another Victim
Tiny Allon Therapeutics had an ambitious plan to go after progressive supranuclear palsy, a kind of progressive brain deterioration, and thence (they hoped) to other neurodegenerative disorders. The l...
Transmission of tangles in Alzheimer's mice provides more authentic model of tau pathology
Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs)...
Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs)...
Treating Progressive Supranuclear Palsy
Identifying symptoms correctly and using collaborative approach improves PT outcomes.
Allon plummets on davunetide update
Allon Therapeutics Inc. (TSX:NPC) fell C$0.41 (94%) to C$0.03 on Tuesday after the company said it will not allocate any additional capital to R&D for davunetide and will take immediate action to redu...
Sedentary behavior worsens decline in cerebral palsy
(HealthDay)—Adults with cerebral palsy may be able to reduce declines in muscle strength, improve function, and reduce cardiovascular and metabolic disease by avoiding sedentary behavior and engagin...
Matching PubMed Articles
Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy.
Progressive supranuclear palsy (PSP) is a relatively common neurodegenerative tauopathy clinically characterized by parkinsonism, axial rigidity, and supranuclear gaze palsy. Pathologic findings of PS...
Progressive Supranuclear Palsy.
Progressive supranuclear palsy (PSP) is the second-most-common parkinsonian neurodegenerative disorder following Parkinson's disease. Although PSP was first identified clinically more than 40 years ag...
Functional disturbance of the locomotor network in progressive supranuclear palsy.
To determine pathologic regulations and potential compensatory mechanisms in the supraspinal locomotor network of patients with progressive supranuclear palsy (PSP) by investigation of brain activatio...
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Progressive supranuclear palsy presenting with urinary retention and sleep apnea.
We report a case of a 62-year-old Japanese-Australian woman with progressive supranuclear palsy (PSP) who presented with prominent urinary retention, neurogenic changes in sphincter electromyography,...
